Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study - E BioMedicine, October 2016
Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study - Diabetes Care, July 2015
Mesenchymal Precursor Cell Therapy for Diabetic Nephropathy: A Phase 2 Randomized Controlled Trial - 75th Scientific Sessions of the American Diabetes Association, June 2015
Effect of Mesenchymal Precursor Cells on the Systemic Inflammatory Response and Endothelial Dysfunction in an Ovine Model of Collagen-Induced Arthritis - PLOS One, May 2015
Treatment of Inflammatory Diseases with Mesenchymal Stem Cells - Inflammation & Allergy, 2009